Differential gene expression in anaplastic lymphoma kinase–positive and anaplastic lymphoma kinase–negative anaplastic large cell lymphomas-Reference-Cited by-同舟云学术

Differential gene expression in anaplastic lymphoma kinase–positive and anaplastic lymphoma kinase–negative anaplastic large cell lymphomas

Published:2005-05 Issue:5 Volume:36 Page:494-504
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Thompson Mary Ann,Stumph Jennifer,Henrickson Sarah E.,Rosenwald Andreas,Wang QiFu,Olson Sandy,Brandt Stephen J.,Roberts Jeremy,Zhang Xueqiong,Shyr Yu,Kinney Marsha C.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference35 articles.

1. ALK+ CD30+ lymphomas: a distinct molecular genetic subtype of non–Hodgkin's lymphoma;Morris;Br J Haematol,2001

2. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non–Hodgkin's lymphoma;Morris;Science,1994

3. ALK-positive lymphoma: a single disease with a broad spectrum of morphology;Benharroch;Blood,1998

4. Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth;Chan;Biochemistry,1989

5. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1;Pulford;Blood,1997

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of CDKL: An underestimated protein kinase family;International Journal of Biological Macromolecules;2024-10

2. Current views on the etiology and pathogenesis of ALK-positive anaplastic large cell lymphoma;Pediatric Hematology/Oncology and Immunopathology;2024-04-08

3. Editorial: How to circumvent the tumour-promoting effect of cytokine in tumour therapy;Frontiers in Immunology;2023-10-10

4. Multiomics of three hematological malignancies in a patient reveal their origin from clonal hematopoietic stem cells;Blood Cancer Journal;2023-08-09

5. Cell division cycle 37 change after bortezomib-based induction therapy helps to predict clinical response and prognosis in multiple myeloma patients;Hematology;2023-07-06